GNA Biosolutions offers patients precisely that at the point-of-care. In the process, the specific DNA sequences of the sought-after pathogen are extracted and then artificially duplicated through a laser-based polymerase chain reaction. Since the sample does not need to be particularly pure, the procedure enables the development of low-cost diagnostic products.